Literature DB >> 9636650

Endothelial cells differentially express functional CXC-chemokine receptor-4 (CXCR-4/fusin) under the control of autocrine activity and exogenous cytokines.

C Feil1, H G Augustin.   

Abstract

Analysis of endothelial cell (EC) chemokine receptor expression by RT-PCR revealed that EC essentially do not express CC-chemokine receptors whereas they express all known CXC-chemokine receptors. Endotheliotropic functions of ligands for CXCR-1, CXCR-2, and CXCR-3 have previously been described. We have consequently performed a detailed analysis of endothelial CXCR-4 expression. CXCR-4 is constitutively expressed by quiescent, resting EC. Cytokine stimulation revealed that bFGF upregulates endothelial CXCR-4 expression, whereas TNF alpha downregulates endothelial CXCR-4 expression. Expression of CXCR-4 mRNA as well as protein is also upregulated in autocrine activated, migrating bovine aortic endothelial cells (BAEC). Furthermore, migrating BAEC preferentially present CXCR-4 on the cell surface as evidenced by cytochemistry and FACS analysis. Lastly, the monospecific CXCR-4 ligand SDF-1 was found to act as a potent inducer of EC chemotaxis. In summary, the data indicate that the CXCR-4/SDF-1 receptor ligand interaction may be an important regulator of activated endothelial cell functions as they occur during vascular remodeling and angiogenesis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9636650     DOI: 10.1006/bbrc.1998.8499

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  41 in total

1.  CXC chemokine receptor 4 expression and stromal cell-derived factor-1alpha-induced chemotaxis in CD4+ T lymphocytes are regulated by interleukin-4 and interleukin-10.

Authors:  T Jinquan; S Quan; H H Jacobi; H O Madsen; C Glue; P S Skov; H J Malling; L K Poulsen
Journal:  Immunology       Date:  2000-03       Impact factor: 7.397

2.  Stromal-cell derived factor is expressed by dendritic cells and endothelium in human skin.

Authors:  J L Pablos; A Amara; A Bouloc; B Santiago; A Caruz; M Galindo; T Delaunay; J L Virelizier; F Arenzana-Seisdedos
Journal:  Am J Pathol       Date:  1999-11       Impact factor: 4.307

3.  Roles of mechanical force and CXCR1/CXCR2 in shear-stress-induced endothelial cell migration.

Authors:  Ye Zeng; Yang Shen; Xian-Liang Huang; Xiao-Jing Liu; Xiao-Heng Liu
Journal:  Eur Biophys J       Date:  2011-10-12       Impact factor: 1.733

Review 4.  The Role of Chemokines in Fibrotic Wound Healing.

Authors:  Jie Ding; Edward E Tredget
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-11-01       Impact factor: 4.730

Review 5.  Regulation of CXCR4 signaling.

Authors:  John M Busillo; Jeffrey L Benovic
Journal:  Biochim Biophys Acta       Date:  2006-11-10

6.  mTORC2 mediates CXCL12-induced angiogenesis.

Authors:  Mary E Ziegler; Michaela M S Hatch; Nan Wu; Steven A Muawad; Christopher C W Hughes
Journal:  Angiogenesis       Date:  2016-04-22       Impact factor: 9.596

7.  The chemokine receptor CCR2 mediates the binding and internalization of monocyte chemoattractant protein-1 along brain microvessels.

Authors:  K A Dzenko; A V Andjelkovic; W A Kuziel; J S Pachter
Journal:  J Neurosci       Date:  2001-12-01       Impact factor: 6.167

8.  Effects of antisecretory agents on angiogenesis during healing of gastric ulcers.

Authors:  Masumi Akimoto; Hiroshi Hashimoto; Mutsuo Shigemoto; Atsushi Maeda; Katsuko Yamashita
Journal:  J Gastroenterol       Date:  2005-07       Impact factor: 7.527

9.  A destructive cascade mediated by CCL2 facilitates prostate cancer growth in bone.

Authors:  Xin Li; Robert Loberg; Jinhui Liao; Chi Ying; Linda A Snyder; Kenneth J Pienta; Laurie K McCauley
Journal:  Cancer Res       Date:  2009-01-27       Impact factor: 12.701

Review 10.  Role of the CXCR4/CXCL12 signaling axis in breast cancer metastasis to the brain.

Authors:  Cimona V Hinton; Shalom Avraham; Hava Karsenty Avraham
Journal:  Clin Exp Metastasis       Date:  2008-09-24       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.